Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 3 Regulatory News (DNA3)

  • There is currently no data for DNA3

Statement re Acquisition of Aircraft

30 Aug 2013 16:00

RNS Number : 9004M
Doric Nimrod Air Three Limited
30 August 2013
 



NOT FOR DISTRIBUTION OR RELEASE IN ANY JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW

DORIC NIMROD AIR THREE LIMITED

DNA ALPHA LIMITED

Acquisition of the first aircraft

30 August 2013

 

Doric Nimrod Air Three Limited ("DNA3") and its wholly-owned subsidiary DNA Alpha Limited ("DNA Alpha") are pleased to announce that DNA Alpha, on 29 August 2013 purchased an Airbus A380-861 aircraft bearing manufacturer's serial number 132 (the "Aircraft") for the sum of US$245,000,000.

 

DNA Alpha also entered into an Aircraft Operating Lease Agreement with Emirates pursuant to which the Aircraft would be leased to Emirates.

 

The remaining three Airbus A380 aircraft to be acquired pursuant to the Initial Investment Process outlined in the DNA3 Prospectus dated 20 June 2013 are anticipated to be purchased in the fourth Quarter 2013.

 

About the Company

DNA3 is a Guernsey domiciled company with shares admitted to the official list of the Channel Islands Stock Exchange and to trading on the Specialist Fund Market of the London Stock Exchange (LSE:DNA3).

DNA Alpha is a Guernsey domiciled company with pass through certificates admitted to listing on the Official List and trading on the Main Securities Market of the Irish Stock Exchange.

DNA3's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft (the "Assets").

To pursue its investment objective, DNA3 will seek to use the net proceeds of placings and other equity capital raisings, together with debt facilities (or instruments), to initially acquire Airbus A380 aircraft which will be leased to Emirates Airlines.

 

The Company aims to provide Shareholders with an attractive total return comprising income, from distributions through the period of the Company's ownership of the Assets, and capital, upon the sale of the Assets.

For further information, please contact:

For administrative and company information:

Anson Fund Managers Limited

+44 (0) 1481 722260

 

 For shareholder information:

Nimrod Capital LLP

Richard Bolchover

Marc Gordon

+44 (0) 20 3355 6855

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFEVTSIIVIV
Date   Source Headline
16th Jan 20267:01 amRNSCancellation of Trading on the LSE
16th Jan 20267:00 amRNSCompletion of Compulsory Redemption of Shares
8th Jan 20264:05 pmRNSCompulsory Redemption of Shares
11th Dec 20253:40 pmRNSUpdate - Anticipated Redemption of Shares
11th Dec 20253:16 pmRNSUnaudited Interim Financial Report
4th Dec 20252:45 pmRNSResult of AGM
19th Nov 202510:18 amRNSNotice of AGM
17th Nov 20252:08 pmRNSASSET SALE UPDATE
30th Oct 20253:39 pmRNSASSET SALE UPDATE
14th Oct 20254:05 pmRNSQuarterly Factsheet
14th Oct 20254:01 pmRNSDividend Declaration
3rd Sep 20252:41 pmRNSHolding(s) in Company
1st Sep 20254:03 pmRNSASSET SALE UPDATE
28th Aug 202512:14 pmRNSASSET SALE UPDATE
24th Jul 202510:29 amRNSAnnual Financial Report
14th Jul 20254:51 pmRNSQuarterly Factsheet
11th Jul 20258:02 amRNSSALE OF ASSETS
10th Jul 20252:40 pmRNSDividend Declaration
10th Apr 20254:34 pmRNSQuarterly Factsheet
10th Apr 20254:18 pmRNSDividend Declaration
14th Jan 20254:12 pmRNSQuarterly Factsheet
14th Jan 20254:10 pmRNSDividend Declaration
12th Dec 20243:29 pmRNSUNAUDITED INTERIM FINANCIAL REPORT
5th Dec 20245:58 pmRNSResult of AGM
18th Nov 20243:26 pmRNSNotice of AGM
15th Oct 20244:44 pmRNSQuarterly Factsheet
15th Oct 20244:42 pmRNSDividend Declaration
24th Jul 20247:00 amRNSAnnual Financial Report
11th Jul 20244:06 pmRNSDividend Declaration
11th Jul 20244:05 pmRNSQuarterly Factsheet
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:05 pmRNSDividend Declaration
28th Mar 20249:22 amRNSMSN 133 REDELIVERY CONDITION
15th Mar 20249:24 amRNSMSN 134 REDELIVERY CONDITION
4th Mar 202412:46 pmRNSMSN 136 REDELIVERY CONDITION
11th Jan 20244:21 pmRNSQuarterly Report
11th Jan 20244:19 pmRNSDividend Declaration
4th Jan 20244:07 pmRNSMSN132 REDELIVERY CONDITION
15th Dec 20232:45 pmRNSUnaudited Interim Financial Report
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:47 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:43 pmRNSAnnual Financial Report
13th Jul 20234:59 pmRNSQuarterly Report
13th Jul 20234:58 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:04 pmRNSDividend Declaration
13th Apr 20235:04 pmRNSQuarterly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.